Table 1:
Patient Characteristics
| Patient Characteristics | ND | DM | P values |
|---|---|---|---|
| Age (y)* | 73 ± 10 | 69 ± 9.0 | 0.40 |
| Number of cases | 12 | 12 | 1.00 |
| Male n(%) | 10 (%) | 9 (%) | 1.00 |
| HbA1c (%)* | 5.3 ± 0.33 | 8.2 ± 0.84 | 0.0001 |
| Blood Glucose (mg/dL)* | 112 ± 14.0 | 156 ± 20.2 | 0.0005 |
| Obesity (BMI>30) n(%) | 3 (25.0%) | 7 (58.3%) | 0.21 |
| Hypertension n(%) | 3 (25.0%) | 9 (75%) | 0.04 |
| Atrial fibrillation n(%) | 1 (8.3%) | 1 (8.3%) | 1.00 |
| Heart failure n(%) | 1 (8.3%) | 2 (16.7%) | 1.00 |
| Hypercholesterolemia n(%) | 3 (25.0%) | 9 (75%) | 0.04 |
| Valve replacement n(%) | 9 (75%) | 1 (8.3%) | 0.003 |
| CABG only n(%) | 0 (%) | 9 (75%) | 0.0003 |
| CABG + Valve replacement n(%) | 2 (16.6%) | 2 (16.7%) | 1.00 |
| Pre-operative aspirin n(%) | 3 (25.0%) | 8 (66.7%) | 0.09 |
| Pre-operative β-blocker n(%) | 1 (8.3%) | 7 (58.3%) | 0.03 |
| Pre-operative CaCB n(%) | 1 (8.3%) | 5 (41.6%) | 0.16 |
| Pre-operative ACEI n(%) | 2 (16.7%) | 6 (50.0%) | 0.19 |
| Pre-operative statin n(%) | 3 (25.0%) | 9 (75.0%) | 0.04 |
ND: non-diabetes; DM: diabetes; BMI: body mass index; CABG: coronary artery bypass grafting; CaCB: calcium channel blocker; ACEI: angiotensin converting enzyme inhibitor
Data expressed as mean ± SD.